Delivery Method: VIA UPS Product: DrugsFood & Beverages Recipient: Recipient Name Yvan P. Rochon, PhD Recipient Title President Herbal Vitality, Inc. 2810 Hopi DrSedona, AZ 86336-3733United […]

Date: May 7 – 8, 2026 Day1: Thu, May 07 9:00 a.m. – 04:15 p.m. ET Day2: Fri, May 08 9:00 a.m. – 12:40 p.m. ET […]

en Español (PDF – 226 KB) 6-1-2022 Comunicado de la FDA sobre la seguridad de los medicamentos Debido a preocupaciones de seguridad, la Administración de Alimentos […]

Date: August 25, 2026 Time: 10:00 a.m. – 4:30 p.m. ET Location: Event Location Attend In Person or OnlineVirtual: via webcastIn Person: FDA White Oak Campus […]

Laws, Regulations, Guidances, and Compliance Letters Some of the links from this page take you to other government web sites. Once you leave this page, click […]

La FDA había comunicado con anterioridad sobre el ensayo clínico de seguridad con el Xeljanz y Xeljanz de liberación prolongada (tofacitinib) en febrero de 2019 y […]

Product: Animal & VeterinaryDrugs Recipient: Recipient Name Janice L. Erickson Recipient Title Owner Meds For Vets, LLC 9550 S State StSandy, UT 84070-3211United States (b)(6), (b)(7)(C) […]

Today, FDA released Draft Guidance for Industry: Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality Considerations. This draft guidance describes the Agency’s recommendations […]

[10/4/2018] The Food and Drug Administration is alerting consumers and pet owners about a voluntary recall of certain lots of eight products – six products for […]